$SY
So-Young International Inc. Stock $sy

$sy Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000110465924051493 Filed on April 25, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$390.6M	$1.498B
YoY Change	20.12%	19.09%
Cost Of Revenue	$137.6M	$544.3M
YoY Change	56.04%	38.41%
Gross Profit	$252.9M	$953.7M
YoY Change	6.75%	10.31%
Gross Profit Margin	64.76%	63.66%
Selling, General & Admin	$212.8M	$811.2M
YoY Change	24.08%	10.78%
% of Gross Profit	84.15%	85.06%
Research & Development	$44.99M	$203.5M
YoY Change	9.56%	-13.43%
% of Gross Profit	17.79%	21.34%
Depreciation & Amortization		$6.492M
YoY Change		-4.91%
% of Gross Profit		0.68%
Operating Expenses	$257.8M	$1.015B
YoY Change	21.28%	4.89%
Operating Profit	-$4.904M	-$61.05M
YoY Change	-120.14%	-40.62%
Interest Expense	$10.31M	$47.46M
YoY Change	137.03%	207.56%
% of Operating Profit
Other Income/Expense, Net	$3.424M	$21.90M
YoY Change	430.03%	165.56%
Pretax Income	$8.389M	$7.869M
YoY Change	-71.41%	-109.04%
Income Tax	-$10.84M	-$18.08M
% Of Pretax Income	-129.16%	-229.7%
Net Earnings	$17.50M	$21.28M
YoY Change	-44.04%	-132.46%
Net Earnings / Revenue	4.48%	1.42%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.23	$0.27
COMMON SHARES
Basic Shares Outstanding		77.65M
Diluted Shares Outstanding		78.05M

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.327B	$1.327B
YoY Change	-15.5%	-15.5%
Cash & Equivalents	$426.1M	$426.1M
Short-Term Investments	$900.8M	$900.8M
Other Short-Term Assets	$186.5M	$186.5M
YoY Change	31.5%	31.5%
Inventory	$118.9M	$118.9M
Prepaid Expenses
Receivables	$80.38M	$80.38M
Other Receivables	$9.212M	$9.212M
Total Short-Term Assets	$1.722B	$1.722B
YoY Change	-10.17%	-10.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$235.2M	$235.2M
YoY Change	31.33%	31.33%
Goodwill	$540.7M
YoY Change	0.0%
Intangibles	$145.3M
YoY Change	-14.19%
Long-Term Investments	$261.0M	$261.0M
YoY Change	14.5%	14.5%
Other Assets	$310.5M	$310.5M
YoY Change	89.29%	89.29%
Total Long-Term Assets	$1.493B	$1.493B
YoY Change	16.52%	16.52%
TOTAL ASSETS
Total Short-Term Assets	$1.722B	$1.722B
Total Long-Term Assets	$1.493B	$1.493B
Total Assets	$3.215B	$3.215B
YoY Change	0.52%	0.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$388.0K	$388.0K
YoY Change	-93.42%	-93.42%
Accrued Expenses	$349.9M	$349.9M
YoY Change	0.73%	0.73%
Deferred Revenue	$103.4M
YoY Change	-6.16%
Short-Term Debt	$29.83M	$29.83M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$540.4M	$540.4M
YoY Change	0.44%	0.44%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$87.75M	$87.75M
YoY Change	318.4%	318.4%
Total Long-Term Liabilities	$87.75M	$87.75M
YoY Change	318.4%	318.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$540.4M	$540.4M
Total Long-Term Liabilities	$87.75M	$87.75M
Total Liabilities	$770.4M	$770.4M
YoY Change	10.07%	10.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$330.2M
YoY Change	-4.75%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.444B	$2.444B
YoY Change
Total Liabilities & Shareholders Equity	$3.215B	$3.215B
YoY Change	0.52%	0.52%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$17.50M	$21.28M
YoY Change	-44.04%	-132.46%
Depreciation, Depletion And Amortization		$6.492M
YoY Change		-4.91%
Cash From Operating Activities		$22.50M
YoY Change		-119.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$28.54M
YoY Change		-65.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-14.09M
YoY Change		615.08%
NET CHANGE
Cash From Operating Activities		22.50M
Cash From Investing Activities		-28.54M
Cash From Financing Activities		-14.09M
Net Change In Cash		-37.78M
YoY Change		-59.46%
FREE CASH FLOW
Cash From Operating Activities		$22.50M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Restricted Cash Asset Statement Of Financial Position Extensible List RestrictedCashAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#RestrictedCashAndCashEquivalentsAtCarryingValue
CY2023Q4	us-gaap	Restricted Cash Asset Statement Of Financial Position Extensible List RestrictedCashAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#RestrictedCashAndCashEquivalentsAtCarryingValue
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001758530
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	us-gaap	Operating Cost And Expense Related Party Type Extensible Enumeration OperatingCostAndExpenseRelatedPartyTypeExtensibleEnumeration	http://fasb.org/srt/2023#AffiliatedEntityMember
CY2022	us-gaap	Operating Cost And Expense Related Party Type Extensible Enumeration OperatingCostAndExpenseRelatedPartyTypeExtensibleEnumeration	http://fasb.org/srt/2023#AffiliatedEntityMember
CY2023	us-gaap	Operating Cost And Expense Related Party Type Extensible Enumeration OperatingCostAndExpenseRelatedPartyTypeExtensibleEnumeration	http://fasb.org/srt/2023#AffiliatedEntityMember
CY2021	us-gaap	Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2022	us-gaap	Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2023	us-gaap	Government Assistance Statement Of Income Or Comprehensive Income Extensible Enumeration GovernmentAssistanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2021Q4	us-gaap	Restricted Cash Asset Statement Of Financial Position Extensible List RestrictedCashAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#RestrictedCashAndCashEquivalentsAtCarryingValue
CY2023	us-gaap	Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38878
CY2023	dei	Entity Registrant Name EntityRegistrantName	So-Young International Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Tower E, Ronsin Technology Center
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Chaoyang District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100012
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Security12b Title Security12bTitle	Class A ordinary shares
CY2023	dei	Trading Symbol TradingSymbol	SY
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1424
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers Zhong Tian LLP
CY2023	dei	Auditor Location AuditorLocation	Beijing, the People’s Republic of China
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	694420000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	426119000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60018000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14908000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14695000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2070000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36006000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57219000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8059000
CY2022Q4	us-gaap	Inventory Net InventoryNet	120480000
CY2023Q4	us-gaap	Inventory Net InventoryNet	118924000
CY2023Q4	us-gaap	Inventory Net InventoryNet	16750000
CY2022Q4	sy	Receivables From Online Payment Platforms ReceivablesFromOnlinePaymentPlatforms	14787000
CY2023Q4	sy	Receivables From Online Payment Platforms ReceivablesFromOnlinePaymentPlatforms	23158000
CY2023Q4	sy	Receivables From Online Payment Platforms ReceivablesFromOnlinePaymentPlatforms	3262000
CY2022Q4	sy	Term Deposits And Short Term Investments TermDepositsAndShortTermInvestments	875955000
CY2023Q4	sy	Term Deposits And Short Term Investments TermDepositsAndShortTermInvestments	900823000
CY2023Q4	sy	Term Deposits And Short Term Investments TermDepositsAndShortTermInvestments	126878000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	126889000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	171774000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24194000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1916827000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1721924000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	242528000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	227959000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	261016000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	36763000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	169280000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	145253000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20458000
CY2022Q4	us-gaap	Goodwill Goodwill	540693000
CY2023Q4	us-gaap	Goodwill Goodwill	540693000
CY2023Q4	us-gaap	Goodwill Goodwill	76155000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116184000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116782000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16448000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	64739000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	78034000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10991000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	62898000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118408000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16677000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	99293000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	232455000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32741000
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1281046000
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1492641000
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	210233000
CY2022Q4	us-gaap	Assets Assets	3197873000
CY2023Q4	us-gaap	Assets Assets	3214565000
CY2023Q4	us-gaap	Assets Assets	452761000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	29825000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	4201000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	74580000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	56894000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8013000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	110159000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	103374000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14560000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	72532000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	86290000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12154000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5895000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	388000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	55000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	224589000
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	233913000
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	32945000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50285000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29739000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4189000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	538040000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	540423000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	76117000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20972000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	86210000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12142000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	30993000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	25082000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3533000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1536000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	216000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	51965000
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	112828000
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15891000
CY2022Q4	us-gaap	Liabilities Liabilities	590005000
CY2023Q4	us-gaap	Liabilities Liabilities	653251000
CY2023Q4	us-gaap	Liabilities Liabilities	92008000
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	232835000
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	358453000
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	50487000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3043971000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3080433000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	433870000
CY2022Q4	sy	Statutory Reserve StatutoryReserve	29027000
CY2023Q4	sy	Statutory Reserve StatutoryReserve	33855000
CY2023Q4	sy	Statutory Reserve StatutoryReserve	4768000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346618000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-330166000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46503000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4107000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18185000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2561000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2497925000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2444129000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	344248000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	109943000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	117185000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	16505000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2607868000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2561314000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	360753000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3197873000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3214565000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	452761000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1692463000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1257874000
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1498029000
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	210993000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	327889000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	393292000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	544336000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	76668000
CY2021	us-gaap	Gross Profit GrossProfit	1364574000
CY2022	us-gaap	Gross Profit GrossProfit	864582000
CY2023	us-gaap	Gross Profit GrossProfit	953693000
CY2023	us-gaap	Gross Profit GrossProfit	134325000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	792484000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	472092000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	520451000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	73304000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	252214000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	260208000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	290765000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40953000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	286567000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	235087000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	203524000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28666000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	65879000
CY2021	us-gaap	Operating Expenses OperatingExpenses	1397144000
CY2022	us-gaap	Operating Expenses OperatingExpenses	967387000
CY2023	us-gaap	Operating Expenses OperatingExpenses	1014740000
CY2023	us-gaap	Operating Expenses OperatingExpenses	142923000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-32570000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-102805000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-61047000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8598000
CY2021	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	8931000
CY2022	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	4264000
CY2023	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	12004000
CY2023	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	1691000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	19328000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	28883000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	48843000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	6879000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4766000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-492000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-662000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-93000
CY2021	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	17850000
CY2022	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	7945000
CY2023	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	444000
CY2023	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	63000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1522000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-17223000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12723000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1792000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12044000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8246000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21898000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3084000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16405000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87072000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7869000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1108000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21231000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20965000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18075000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2546000
CY2021	us-gaap	Profit Loss ProfitLoss	-37636000
CY2022	us-gaap	Profit Loss ProfitLoss	-66107000
CY2023	us-gaap	Profit Loss ProfitLoss	25944000
CY2023	us-gaap	Profit Loss ProfitLoss	3654000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-29265000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-553000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4664000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	657000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8371000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-65554000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	21280000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2997000
CY2021	us-gaap	Profit Loss ProfitLoss	-37636000
CY2022	us-gaap	Profit Loss ProfitLoss	-66107000
CY2023	us-gaap	Profit Loss ProfitLoss	25944000
CY2023	us-gaap	Profit Loss ProfitLoss	3654000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	31399000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-87998000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-14078000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-1983000
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	31399000
CY2022	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-87998000
CY2023	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-14078000
CY2023	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-1983000
CY2021	sy	Comprehensive Income Net Of Tax Before Temporary Equity Accretion To Redemption Value ComprehensiveIncomeNetOfTaxBeforeTemporaryEquityAccretionToRedemptionValue	-69035000
CY2022	sy	Comprehensive Income Net Of Tax Before Temporary Equity Accretion To Redemption Value ComprehensiveIncomeNetOfTaxBeforeTemporaryEquityAccretionToRedemptionValue	21891000
CY2023	sy	Comprehensive Income Net Of Tax Before Temporary Equity Accretion To Redemption Value ComprehensiveIncomeNetOfTaxBeforeTemporaryEquityAccretionToRedemptionValue	40022000
CY2023	sy	Comprehensive Income Net Of Tax Before Temporary Equity Accretion To Redemption Value ComprehensiveIncomeNetOfTaxBeforeTemporaryEquityAccretionToRedemptionValue	5637000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-29265000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-553000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4664000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	657000
CY2021	sy	Comprehensive Income Loss Net Of Tax Attributable To So Young International Inc ComprehensiveIncomeLossNetOfTaxAttributableToSoYoungInternationalInc	-39770000
CY2022	sy	Comprehensive Income Loss Net Of Tax Attributable To So Young International Inc ComprehensiveIncomeLossNetOfTaxAttributableToSoYoungInternationalInc	22444000
CY2023	sy	Comprehensive Income Loss Net Of Tax Attributable To So Young International Inc ComprehensiveIncomeLossNetOfTaxAttributableToSoYoungInternationalInc	35358000
CY2023	sy	Comprehensive Income Loss Net Of Tax Attributable To So Young International Inc ComprehensiveIncomeLossNetOfTaxAttributableToSoYoungInternationalInc	4980000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81680504
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82665269
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77646899
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77646899
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81680504
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82665269
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78054950
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78054950
CY2021	sy	Number Of Ads Per Ten Ordinary Shares NumberOfAdsPerTenOrdinaryShares	13
CY2022	sy	Number Of Ads Per Ten Ordinary Shares NumberOfAdsPerTenOrdinaryShares	13
CY2023	sy	Number Of Ads Per Ten Ordinary Shares NumberOfAdsPerTenOrdinaryShares	13
CY2021	sy	Number Of Ordinary Shares For Each Ads NumberOfOrdinarySharesForEachAds	10
CY2022	sy	Number Of Ordinary Shares For Each Ads NumberOfOrdinarySharesForEachAds	10
CY2023	sy	Number Of Ordinary Shares For Each Ads NumberOfOrdinarySharesForEachAds	10
CY2021	sy	Number Of Ads Per Ten Ordinary Shares NumberOfAdsPerTenOrdinaryShares	13
CY2022	sy	Number Of Ads Per Ten Ordinary Shares NumberOfAdsPerTenOrdinaryShares	13
CY2023	sy	Number Of Ads Per Ten Ordinary Shares NumberOfAdsPerTenOrdinaryShares	13
CY2021	sy	Number Of Ordinary Shares For Each Ads NumberOfOrdinarySharesForEachAds	10
CY2022	sy	Number Of Ordinary Shares For Each Ads NumberOfOrdinarySharesForEachAds	10
CY2023	sy	Number Of Ordinary Shares For Each Ads NumberOfOrdinarySharesForEachAds	10
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2596371000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8371000
CY2021	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	76905000
CY2021	sy	Stock Repurchased During Period Values StockRepurchasedDuringPeriodValues	217712000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	106150000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1150000
CY2021	sy	Reclassification Of Non Controlling Interests In Equity And Net Loss Attributable To Non Controlling Interest Shareholders ReclassificationOfNonControllingInterestsInEquityAndNetLossAttributableToNonControllingInterestShareholders	6060000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31399000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2517034000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2517034000
CY2022	us-gaap	Profit Loss ProfitLoss	-66107000
CY2022	sy	Stock Repurchased During Period Values StockRepurchasedDuringPeriodValues	15123000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43336000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1079000
CY2022	sy	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	661000
CY2022	sy	Non Controlling Interest Change Of Capital From Non Controlling Interest Share Holder NonControllingInterestChangeOfCapitalFromNonControllingInterestShareHolder	38990000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	87998000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2607868000
CY2023	us-gaap	Profit Loss ProfitLoss	25944000
CY2023	sy	Stock Repurchased During Period Values StockRepurchasedDuringPeriodValues	125618000
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4464000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36321000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	143000
CY2023	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	6992000
CY2023	sy	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	50000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14078000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2561314000
CY2021	us-gaap	Profit Loss ProfitLoss	-37636000
CY2022	us-gaap	Profit Loss ProfitLoss	-66107000
CY2023	us-gaap	Profit Loss ProfitLoss	25944000
CY2023	us-gaap	Profit Loss ProfitLoss	3654000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30081000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47086000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46090000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6492000
CY2022	sy	Inventory Provision InventoryProvision	-1681000
CY2023	sy	Inventory Provision InventoryProvision	-734000
CY2023	sy	Inventory Provision InventoryProvision	-103000
CY2021	sy	Impairment Of Notes Receivable Related Parties ImpairmentOfNotesReceivableRelatedParties	860000
CY2021	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	17850000
CY2022	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	7945000
CY2023	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	444000
CY2023	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	63000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1350000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	844000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	119000
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	5421000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	65879000
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	5497000
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	774000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-244000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-136000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-19000
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	2842000
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	400000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15498000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13224000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15629000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2201000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	106150000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	43336000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	36321000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5116000
CY2021	sy	Lease Expense To Reduce Right Of Use Assets LeaseExpenseToReduceRightOfUseAssets	33668000
CY2022	sy	Lease Expense To Reduce Right Of Use Assets LeaseExpenseToReduceRightOfUseAssets	38588000
CY2023	sy	Lease Expense To Reduce Right Of Use Assets LeaseExpenseToReduceRightOfUseAssets	45699000
CY2023	sy	Lease Expense To Reduce Right Of Use Assets LeaseExpenseToReduceRightOfUseAssets	6437000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1522000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-17223000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12723000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1792000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4766000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-492000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-662000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-93000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1652000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24803000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-33515000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4720000
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8289000
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-49000
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	492000
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	69000
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-3534000
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-498000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14580000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13564000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28950000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4078000
CY2021	sy	Increase Decrease In Receivables From Online Payment Platforms IncreaseDecreaseInReceivablesFromOnlinePaymentPlatforms	2682000
CY2022	sy	Increase Decrease In Receivables From Online Payment Platforms IncreaseDecreaseInReceivablesFromOnlinePaymentPlatforms	-4077000
CY2023	sy	Increase Decrease In Receivables From Online Payment Platforms IncreaseDecreaseInReceivablesFromOnlinePaymentPlatforms	8371000
CY2023	sy	Increase Decrease In Receivables From Online Payment Platforms IncreaseDecreaseInReceivablesFromOnlinePaymentPlatforms	1179000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	43991000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	48259000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	50450000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7106000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7869000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	27988000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2122000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	299000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	36968000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	51340000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5682000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-800000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-28306000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-28996000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6014000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-847000
CY2021	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-13010000
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	27243000
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-1630000
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-230000
CY2021	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-4838000
CY2022	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-31092000
CY2023	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	14261000
CY2023	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	2009000
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-307000
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	3898000
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-6499000
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-915000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-35764000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-40505000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-56517000
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-7960000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-21119000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-15603000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	18165000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2558000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84287000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-112873000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22501000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3171000
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	45056000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	15707000
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	51176000
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7208000
CY2021	sy	Payments To Acquire Short Term Investments And Term Deposits PaymentsToAcquireShortTermInvestmentsAndTermDeposits	1919804000
CY2022	sy	Payments To Acquire Short Term Investments And Term Deposits PaymentsToAcquireShortTermInvestmentsAndTermDeposits	1205770000
CY2023	sy	Payments To Acquire Short Term Investments And Term Deposits PaymentsToAcquireShortTermInvestmentsAndTermDeposits	2235423000
CY2023	sy	Payments To Acquire Short Term Investments And Term Deposits PaymentsToAcquireShortTermInvestmentsAndTermDeposits	314853000
CY2021	sy	Proceeds From Maturities Of Short Term Investments And Term Deposits ProceedsFromMaturitiesOfShortTermInvestmentsAndTermDeposits	3052869000
CY2022	sy	Proceeds From Maturities Of Short Term Investments And Term Deposits ProceedsFromMaturitiesOfShortTermInvestmentsAndTermDeposits	764785000
CY2023	sy	Proceeds From Maturities Of Short Term Investments And Term Deposits ProceedsFromMaturitiesOfShortTermInvestmentsAndTermDeposits	2103093000
CY2023	sy	Proceeds From Maturities Of Short Term Investments And Term Deposits ProceedsFromMaturitiesOfShortTermInvestmentsAndTermDeposits	296214000
CY2021	sy	Payments To Acquire Long Term Investment Including Prepayment PaymentsToAcquireLongTermInvestmentIncludingPrepayment	102945000
CY2023	sy	Payments To Acquire Long Term Investment Including Prepayment PaymentsToAcquireLongTermInvestmentIncludingPrepayment	36264000
CY2023	sy	Payments To Acquire Long Term Investment Including Prepayment PaymentsToAcquireLongTermInvestmentIncludingPrepayment	5108000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	180000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	102000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	299000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	42000
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	6570000
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	925000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	636872000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	97492000
CY2021	sy	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	15720000
CY2022	sy	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	18130000
CY2023	sy	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	8330000
CY2023	sy	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	1173000
CY2021	sy	Proceeds From Collection Of Short Term Loans To Related Parties ProceedsFromCollectionOfShortTermLoansToRelatedParties	7170000
CY2023	sy	Proceeds From Collection Of Short Term Loans To Related Parties ProceedsFromCollectionOfShortTermLoansToRelatedParties	18620000
CY2023	sy	Proceeds From Collection Of Short Term Loans To Related Parties ProceedsFromCollectionOfShortTermLoansToRelatedParties	2623000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	339822000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-572212000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-202611000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28538000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	217712000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15123000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	125618000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	17693000
CY2022	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	661000
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	50000
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	7000
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	29825000
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4201000
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	4464000
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	629000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	969000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	876000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	192000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-216743000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13586000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100015000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14087000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-9242000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	55862000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11865000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1670000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	198124000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-642809000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-268260000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37784000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1145685000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1343809000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	701000000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98734000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1343809000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	701000000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	432740000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60950000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-31170000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-11360000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-16257000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2290000
CY2023	sy	Conversion Of Loan Receivable To Long Term Investment ConversionOfLoanReceivableToLongTermInvestment	15115000
CY2023	sy	Conversion Of Loan Receivable To Long Term Investment ConversionOfLoanReceivableToLongTermInvestment	2129000
CY2023	sy	Inventories Transfer To Property And Equipment Net InventoriesTransferToPropertyAndEquipmentNet	4412000
CY2023	sy	Inventories Transfer To Property And Equipment Net InventoriesTransferToPropertyAndEquipmentNet	621000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1331968000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	694420000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	426119000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60018000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	11841000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	6580000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	6621000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	932000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1343809000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	701000000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	432740000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60950000
CY2021	us-gaap	Profit Loss ProfitLoss	-37636000
CY2022	us-gaap	Profit Loss ProfitLoss	-66107000
CY2023	us-gaap	Profit Loss ProfitLoss	25944000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84287000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22501000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-112873000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346618000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-330166000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">(c) Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Group’s consolidated financial statements in conformity with the U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the balance sheet date and reported revenues and expenses during the reported years in the consolidated financial statements and accompanying notes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Significant accounting estimates include, but are not limited to, valuation of acquired intangible assets and property and equipment, impairment of goodwill and definite-lived intangible asset and useful lives of intangible assets. Actual results could differ from those estimates and such differences may be material to the consolidated financial statements.</p>
CY2021	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	7093000
CY2022	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	5066000
CY2023	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	20900000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	126889000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	171774000
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.0999
CY2022Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	875955000
CY2023Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	800512000
CY2022Q4	sy	Long Term Deposits LongTermDeposits	0
CY2023Q4	sy	Long Term Deposits LongTermDeposits	112219000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7089000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29210000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	42434000
CY2021	sy	Accounts Receivable Allowance For Credit Loss From Business Combination AccountsReceivableAllowanceForCreditLossFromBusinessCombination	6623000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15498000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13224000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15629000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2240000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29210000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	42434000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	55823000
CY2021	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	17850000
CY2022	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	7945000
CY2022	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	7945000
CY2023	sy	Impairment Losses Investments Amount ImpairmentLossesInvestmentsAmount	444000
CY2021	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	29265000
CY2022	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	553000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4664000
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	20938000
CY2022Q4	sy	Prepaid Rental And Other Deposits PrepaidRentalAndOtherDeposits	6738000
CY2023Q4	sy	Prepaid Rental And Other Deposits PrepaidRentalAndOtherDeposits	18013000
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">(u) Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Starting from the year of 2023, in light of the better monitoring business development of upstream supply chain, the Group’s revenue generated from sales of cosmetic injectables and sales of equipment and maintenance services is grouped into one line item, which is renamed as sales of medical products and maintenance services. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The sale of cosmetic injectables was previously reported in line item of information services and others. The information services and others for the years of 2021 and 2022 have also been retrospectively updated. The amount reclassified from information services and others to sales of medical products and maintenance services are nil and RMB18.3 million for the years of 2021 and 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Starting from the year of 2023, the previous line item cost of revenues was separated into two line items, which are cost of medical products sold and maintenance services and cost of services and others. Cost of medical products sold and maintenance services primarily consists of expenditures relating to medical products and maintenance services, and the remaining cost of revenues is reclassified into cost of services and others. The cost of medical products sold and maintenance services and cost of services and others for the years of 2021 and 2022 have also been retrospectively reclassified.</p>
CY2021	us-gaap	Advertising Expense AdvertisingExpense	570347000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	254893000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	270304000
CY2022Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	5362000
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	10524000
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	115951000
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	108057000
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	96961000
CY2021Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	70000000
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000
CY2023	sy	Net Profit Appropriation To Statutory Surplus Fund Threshold Percentage NetProfitAppropriationToStatutorySurplusFundThresholdPercentage	0.10
CY2023	sy	Maximum Percentage Surplus Fund Appropriation Not Required MaximumPercentageSurplusFundAppropriationNotRequired	0.50
CY2023	sy	Net Profit Appropriation To Statutory Surplus Fund Threshold Percentage NetProfitAppropriationToStatutorySurplusFundThresholdPercentage	0.10
CY2023	sy	Maximum Percentage Surplus Fund Appropriation Not Required MaximumPercentageSurplusFundAppropriationNotRequired	0.50
CY2021	sy	Appropriation From Profit And Loss Statutory Reserves AppropriationFromProfitAndLossStatutoryReserves	9769000
CY2022	sy	Appropriation From Profit And Loss Statutory Reserves AppropriationFromProfitAndLossStatutoryReserves	8696000
CY2023	sy	Appropriation From Profit And Loss Statutory Reserves AppropriationFromProfitAndLossStatutoryReserves	4828000
CY2022Q4	sy	Prepayment To Inventory Suppliers PrepaymentToInventorySuppliers	5945000
CY2023Q4	sy	Prepayment To Inventory Suppliers PrepaymentToInventorySuppliers	6329000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2382000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6027000
CY2021	sy	Foreign Currency Exchange Appreciation Rate ForeignCurrencyExchangeAppreciationRate	0.023
CY2022	sy	Foreign Currency Exchange Depreciation Rate ForeignCurrencyExchangeDepreciationRate	0.092
CY2023	sy	Foreign Currency Exchange Depreciation Rate ForeignCurrencyExchangeDepreciationRate	0.017
CY2022Q4	sy	Maximum Percentage Of Cash And Cash Equivalents Restricted Cash And Term Deposits In Single Institution MaximumPercentageOfCashAndCashEquivalentsRestrictedCashAndTermDepositsInSingleInstitution	0.41
CY2023Q4	sy	Maximum Percentage Of Cash And Cash Equivalents Restricted Cash And Term Deposits In Single Institution MaximumPercentageOfCashAndCashEquivalentsRestrictedCashAndTermDepositsInSingleInstitution	0.27
CY2022Q4	sy	Loans Receivables Net LoansReceivablesNet	65937000
CY2023Q4	sy	Loans Receivables Net LoansReceivablesNet	79729000
CY2022Q4	sy	Prepayments For Services PrepaymentsForServices	25711000
CY2023Q4	sy	Prepayments For Services PrepaymentsForServices	30214000
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	14814000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	81190000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	73097000
CY2022Q4	sy	Inventory Raw Materials And Supplies Work In Process Gross InventoryRawMaterialsAndSuppliesWorkInProcessGross	57066000
CY2023Q4	sy	Inventory Raw Materials And Supplies Work In Process Gross InventoryRawMaterialsAndSuppliesWorkInProcessGross	62869000
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	17776000
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	17042000
CY2022Q4	us-gaap	Inventory Net InventoryNet	120480000
CY2023Q4	us-gaap	Inventory Net InventoryNet	118924000
CY2020	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1474996000
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1821657000
CY2020	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	18481000
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-39955000
CY2021Q4	us-gaap	Goodwill Goodwill	540693000
CY2022Q4	us-gaap	Goodwill Goodwill	540693000
CY2023Q2	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	7818000
CY2023Q2	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	7104000
CY2023Q2	sy	Equity Securities Fvni Number Of Shares Acquired EquitySecuritiesFvniNumberOfSharesAcquired	357800
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	444000
CY2023Q4	us-gaap	Goodwill Goodwill	540693000
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	589193000
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	540693000
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	48500000
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	48500000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	8931000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	4264000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	7209000
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	232230000
CY2021Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	0
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	20270000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	252500000
CY2022	sy	Share Of Losses Of Equity Method Investee ShareOfLossesOfEquityMethodInvestee	17124000
CY2022	sy	Share Of Losses Of Equity Method Investee ShareOfLossesOfEquityMethodInvestee	17124000
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	8103000
CY2022	sy	Long Term Investment Securities Fair Value Impairment Loss Amount LongTermInvestmentSecuritiesFairValueImpairmentLossAmount	8103000
CY2022	sy	Equity Securities Without Readily Determinable Fair Value Foreign Exchange Adjustment EquitySecuritiesWithoutReadilyDeterminableFairValueForeignExchangeAdjustment	-686000
CY2022	sy	Long Term Investment Foreign Exchange Adjustment LongTermInvestmentForeignExchangeAdjustment	-686000
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	224813000
CY2022Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	0
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3146000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	227959000
CY2023	sy	Equity Securities Without Readily Determinable Fair Value Purchases EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases	10540000
CY2023	sy	Equity Securities Fv Ni Noncurrent Purchases EquitySecuritiesFvNiNoncurrentPurchases	7104000
CY2023	sy	Equity Method Investments Purchases EquityMethodInvestmentsPurchases	33735000
CY2023	sy	Long Term Investments Purchases LongTermInvestmentsPurchases	51379000
CY2023	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	381000
CY2023	sy	Long Term Investments Disposal LongTermInvestmentsDisposal	-381000
CY2023	sy	Equity Method Investment Reduction Of Capital EquityMethodInvestmentReductionOfCapital	-1230000
CY2023	sy	Long Term Investments Reduction Of Capital LongTermInvestmentsReductionOfCapital	-1230000
CY2023	sy	Share Of Losses Of Equity Method Investee ShareOfLossesOfEquityMethodInvestee	12723000
CY2023	sy	Share Of Losses Of Equity Method Investee ShareOfLossesOfEquityMethodInvestee	12723000
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-3534000
CY2023	sy	Long Term Investments Unrealized Gain Loss LongTermInvestmentsUnrealizedGainLoss	-3534000
CY2023	sy	Equity Method Investment Impairment Loss Amount EquityMethodInvestmentImpairmentLossAmount	444000
CY2023	sy	Long Term Investment Securities Fair Value Impairment Loss Amount LongTermInvestmentSecuritiesFairValueImpairmentLossAmount	444000
CY2023	sy	Equity Securities Fv Ni Noncurrent Foreign Exchange Gain Loss EquitySecuritiesFvNiNoncurrentForeignExchangeGainLoss	-10000
CY2023	sy	Long Term Investment Foreign Exchange Adjustment LongTermInvestmentForeignExchangeAdjustment	10000
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	235353000
CY2023Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	3560000
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	22103000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	261016000
CY2021	sy	Impairment Losses Alternate Measurement Method Investments Amount ImpairmentLossesAlternateMeasurementMethodInvestmentsAmount	17850000
CY2022	sy	Impairment Losses Alternate Measurement Method Investments Amount ImpairmentLossesAlternateMeasurementMethodInvestmentsAmount	7945000
CY2023	sy	Impairment Losses Alternate Measurement Method Investments Amount ImpairmentLossesAlternateMeasurementMethodInvestmentsAmount	0
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	169502000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	189100000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51279000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	69435000
CY2022Q4	sy	Accumulated Impairment Of Property Plant And Equipment AccumulatedImpairmentOfPropertyPlantAndEquipment	2039000
CY2023Q4	sy	Accumulated Impairment Of Property Plant And Equipment AccumulatedImpairmentOfPropertyPlantAndEquipment	2883000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116184000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116782000
CY2021	us-gaap	Depreciation Depreciation	15086000
CY2022	us-gaap	Depreciation Depreciation	21648000
CY2023	us-gaap	Depreciation Depreciation	20741000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	232901000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46242000
CY2022Q4	us-gaap	Amount Of Impairment To Carrying Amount Of Regulatory Assets AmountOfImpairmentToCarryingAmountOfRegulatoryAssets	17379000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	169280000
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	213723000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	68470000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	145253000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	17379000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14995000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25438000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25349000
CY2023	sy	Estimated Amortization Expenses Within Two Years EstimatedAmortizationExpensesWithinTwoYears	22874000
CY2023	sy	Estimated Amortization Expenses Within Three Years EstimatedAmortizationExpensesWithinThreeYears	19529000
CY2023	sy	Estimated Amortization Expenses Within Four Years EstimatedAmortizationExpensesWithinFourYears	19458000
CY2023	sy	Estimated Amortization Expenses Within Five Years EstimatedAmortizationExpensesWithinFiveYears	19353000
CY2023	sy	Estimated Amortization Expenses Within Five And Thereafter EstimatedAmortizationExpensesWithinFiveAndThereafter	64039000
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	112219000
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	81497000
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	58035000
CY2022Q4	sy	Prepayments Noncurrent PrepaymentsNoncurrent	840000
CY2023Q4	sy	Prepayments Noncurrent PrepaymentsNoncurrent	42446000
CY2022Q4	sy	Prepaid Rental Deposits Noncurrent PrepaidRentalDepositsNoncurrent	13530000
CY2023Q4	sy	Prepaid Rental Deposits Noncurrent PrepaidRentalDepositsNoncurrent	7812000
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	3426000
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	11943000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	99293000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	232455000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	29825000
CY2023Q4	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.014
CY2023	sy	Urban Construction Tax Rate UrbanConstructionTaxRate	0.07
CY2023	sy	Urban Construction Tax Rate1 UrbanConstructionTaxRate1	0.05
CY2023	sy	Urban Construction Tax Rate2 UrbanConstructionTaxRate2	0.01
CY2023	sy	Education Surcharges Rate EducationSurchargesRate	0.03
CY2023	sy	Local Education Surcharges Rate LocalEducationSurchargesRate	0.02
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	19579000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3838000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15440000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1652000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24803000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-33515000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21231000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20965000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18075000
CY2023Q4	us-gaap	Undistributed Earnings Of Domestic Subsidiaries UndistributedEarningsOfDomesticSubsidiaries	348100000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4101000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-21767000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1967000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	5412000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3899000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-31403000
CY2021	sy	Effective Income Tax Rate Reconciliation At Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRateAmount	5701000
CY2022	sy	Effective Income Tax Rate Reconciliation At Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRateAmount	3413000
CY2023	sy	Effective Income Tax Rate Reconciliation At Preferential Tax Rate Amount EffectiveIncomeTaxRateReconciliationAtPreferentialTaxRateAmount	7059000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14219000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1288000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4302000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21231000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20965000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18075000
CY2021	sy	Income Tax Holiday Income Tax Benefits Per Share Basic IncomeTaxHolidayIncomeTaxBenefitsPerShareBasic	-0.07
CY2022	sy	Income Tax Holiday Income Tax Benefits Per Share Basic IncomeTaxHolidayIncomeTaxBenefitsPerShareBasic	-0.21
CY2023	sy	Income Tax Holiday Income Tax Benefits Per Share Basic IncomeTaxHolidayIncomeTaxBenefitsPerShareBasic	-0.03
CY2021	sy	Income Tax Holiday Income Tax Benefits Per Share Diluted IncomeTaxHolidayIncomeTaxBenefitsPerShareDiluted	-0.07
CY2022	sy	Income Tax Holiday Income Tax Benefits Per Share Diluted IncomeTaxHolidayIncomeTaxBenefitsPerShareDiluted	-0.21
CY2023	sy	Income Tax Holiday Income Tax Benefits Per Share Diluted IncomeTaxHolidayIncomeTaxBenefitsPerShareDiluted	-0.03
CY2022Q4	sy	Deferred Tax Assets Advertising And Promotion Expenses DeferredTaxAssetsAdvertisingAndPromotionExpenses	39287000
CY2023Q4	sy	Deferred Tax Assets Advertising And Promotion Expenses DeferredTaxAssetsAdvertisingAndPromotionExpenses	17643000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	3551000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	2342000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	47288000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	86460000
CY2022Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	5756000
CY2023Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	8937000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	5493000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	5574000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	7534000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9795000
CY2022Q4	sy	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses Long Lived Assets DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLossesLongLivedAssets	5148000
CY2023Q4	sy	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses Long Lived Assets DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLossesLongLivedAssets	1219000
CY2022Q4	sy	Deferred Tax Asset Operating Lease Liability DeferredTaxAssetOperatingLeaseLiability	10993000
CY2023Q4	sy	Deferred Tax Asset Operating Lease Liability DeferredTaxAssetOperatingLeaseLiability	22168000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1897000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1581000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	51215000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55517000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	75732000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	100202000
CY2022Q4	sy	Deferred Tax Liabilities Intangible Assets From Business Combination And Assets Acquisition DeferredTaxLiabilitiesIntangibleAssetsFromBusinessCombinationAndAssetsAcquisition	30993000
CY2023Q4	sy	Deferred Tax Liabilities Intangible Assets From Business Combination And Assets Acquisition DeferredTaxLiabilitiesIntangibleAssetsFromBusinessCombinationAndAssetsAcquisition	25082000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	10993000
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	22493000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	41986000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	47575000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	64739000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	78034000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	30993000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	25082000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35708000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	49927000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	51215000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	14219000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1288000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4302000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	49927000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	51215000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55517000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	507327000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	34480000
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	31038000
CY2022Q4	sy	Individual Income Taxes For Employees Payable Current IndividualIncomeTaxesForEmployeesPayableCurrent	7862000
CY2023Q4	sy	Individual Income Taxes For Employees Payable Current IndividualIncomeTaxesForEmployeesPayableCurrent	7670000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	30666000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	17177000
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1572000
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1009000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	74580000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	56894000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54829000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36006000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57219000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	139155000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	110159000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	103374000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	110159000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	103374000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	135385000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	118960000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	102877000
CY2022	us-gaap	Revenue Practical Expedient Remaining Performance Obligation RevenuePracticalExpedientRemainingPerformanceObligation	true
CY2023	us-gaap	Revenue Practical Expedient Remaining Performance Obligation RevenuePracticalExpedientRemainingPerformanceObligation	true
CY2022Q4	sy	Deposits Payable To Service Providers DepositsPayableToServiceProviders	55198000
CY2023Q4	sy	Deposits Payable To Service Providers DepositsPayableToServiceProviders	52546000
CY2022Q4	sy	Accrued Service Expenses AccruedServiceExpenses	46638000
CY2023Q4	sy	Accrued Service Expenses AccruedServiceExpenses	45270000
CY2022Q4	sy	Advance Payment From Platform User AdvancePaymentFromPlatformUser	71514000
CY2023Q4	sy	Advance Payment From Platform User AdvancePaymentFromPlatformUser	91839000
CY2022Q4	sy	Payable To Service Provider Current PayableToServiceProviderCurrent	20290000
CY2023Q4	sy	Payable To Service Provider Current PayableToServiceProviderCurrent	17528000
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	13202000
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	10566000
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2704000
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3339000
CY2022Q4	sy	Accrued Litigation Liabilities Current AccruedLitigationLiabilitiesCurrent	3611000
CY2023Q4	sy	Accrued Litigation Liabilities Current AccruedLitigationLiabilitiesCurrent	2157000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11432000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10668000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	224589000
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	233913000
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2529000
CY2022	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	3288000
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	3113000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2704000
CY2023	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	3687000
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	3052000
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3339000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	62898000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118408000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	71257000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	115949000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	46169000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	60323000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5979000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	101875000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	33923000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	26551000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	25182000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	22818000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	18839000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	127313000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	11364000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	115949000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M2D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0585
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0451
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	41976000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	44252000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	44252000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	49505000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7929000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5146000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3498000
CY2022Q4	sy	Right Of Use Assets In Relation To Early Terminated Lease RightOfUseAssetsInRelationToEarlyTerminatedLease	0
CY2023Q4	sy	Right Of Use Assets In Relation To Early Terminated Lease RightOfUseAssetsInRelationToEarlyTerminatedLease	0
CY2023Q4	sy	Common Stock Authorized Share Capital CommonStockAuthorizedShareCapital	425000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.4648
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.5264
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.4730
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.5009
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.4850
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.5629
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0103
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0161
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0175
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0407
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0348
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0506
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4526000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.10
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	66255000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1048000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.10
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1774000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.10
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	16088000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1288000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.10
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2512000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.10
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10167000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1147000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.10
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1580000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2193000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	340000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.10
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1739000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.10
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M3D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2742000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1482000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.01
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	622000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.03
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1357000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	311000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.04
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2288000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3814000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1116000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.10
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P8Y10M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4515000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	846000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.10
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y6M21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1334000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1140000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.01
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y7M28D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1900000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.59
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.42
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.00
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	141845000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	74266000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	27065000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	65122000
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	26733000
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	14778000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M17D
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M19D
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M7D
CY2021	us-gaap	Profit Loss ProfitLoss	-37636000
CY2022	us-gaap	Profit Loss ProfitLoss	-66107000
CY2023	us-gaap	Profit Loss ProfitLoss	25944000
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-29265000
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-553000
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	4664000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8371000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65554000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21280000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81680504
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82665269
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77646899
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81680504
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82665269
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78054950
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	3611000
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2157000
CY2021	us-gaap	Legal Fees LegalFees	6150000
CY2022	us-gaap	Legal Fees LegalFees	5918000
CY2023	us-gaap	Legal Fees LegalFees	1084000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1350000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	844000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1692463000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1257874000
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1498029000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	327889000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	393292000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	544336000
CY2021	us-gaap	Gross Profit GrossProfit	1364574000
CY2022	us-gaap	Gross Profit GrossProfit	864582000
CY2023	us-gaap	Gross Profit GrossProfit	953693000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1692463000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1257874000
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1498029000
CY2022Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1087002000
CY2023Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1143936000

Files In Submission

Name	View Source	Status
0001104659-24-051493-index-headers.html	Edgar Link	pending
0001104659-24-051493-index.html	Edgar Link	pending
0001104659-24-051493.txt	Edgar Link	pending
0001104659-24-051493-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sy-20231231.xsd	Edgar Link	pending
sy-20231231x20f.htm	Edgar Link	pending
sy-20231231x20f002.jpg	Edgar Link	pending
sy-20231231xex12d1.htm	Edgar Link	pending
sy-20231231xex12d2.htm	Edgar Link	pending
sy-20231231xex13d1.htm	Edgar Link	pending
sy-20231231xex13d2.htm	Edgar Link	pending
sy-20231231xex15d1.htm	Edgar Link	pending
sy-20231231xex15d2.htm	Edgar Link	pending
sy-20231231xex15d2001.jpg	Edgar Link	pending
sy-20231231xex15d3.htm	Edgar Link	pending
sy-20231231xex15d3001.jpg	Edgar Link	pending
sy-20231231xex8d1.htm	Edgar Link	pending
sy-20231231xex97.htm	Edgar Link	pending
sy-20231231_cal.xml	Edgar Link	unprocessable
sy-20231231_def.xml	Edgar Link	unprocessable
sy-20231231_pre.xml	Edgar Link	unprocessable
sy-20231231x20f_htm.xml	Edgar Link	completed
sy-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SY
So-Young International Inc. Stock $sy

2023 Q4 Form 20-F Financial Statement

#000110465924051493 Filed on April 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SY So-Young International Inc. Stock $sy

2023 Q4 Form 20-F Financial Statement

#000110465924051493 Filed on April 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SY
So-Young International Inc. Stock $sy